MARLBOROUGH, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ®, today announced its financial results for the fourth quarter and ...
This article was originally published on Quiver News, read the full story. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...
In a report released today, William Bonello from Craig-Hallum maintained a Hold rating on Akoya Biosciences (AKYA – Research Report). The ...
MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Monday reported a loss of $8.2 million in its fourth quarter. On a per-share basis, the Marlborough, ...
MARLBOROUGH, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ®, today announced its financial results for the fourth ...
Akoya Biosciences (AKYA) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.22 per share a year ago. These ...
MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Monday reported a loss of $8.2 million in its fourth quarter. On a per-share basis, the Marlborough ...
Zacks Investment Research on MSN2d
Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue EstimatesAkoya Biosciences (AKYA) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.22 per share a year ago. These figures ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback